Cannabielsoin (CBE) is a rare, non-psychoactive cannabinoid found in aged or oxidized cannabis. Formed through the natural breakdown of cannabidiol (CBD), CBE remains one of the most enigmatic molecules in the cannabis world. Its subtle emergence in stored extracts marks the ongoing dance of time and chemistry inside the plant.
CBE’s molecular formula is C₂₁H₃₀O₃, with a molar mass of approximately 330.47 g/mol. The molecule is structurally related to CBD but features additional oxygen, resulting from oxidative ring modifications. CBE typically appears as a colorless oil, classified as a degraded cannabinoid, with an estimated boiling point around 180 °C.
CBE exhibits very low affinity for CB₁ and CB₂ receptors and does not produce psychoactive effects. Its biological activity is not fully understood, though preliminary data suggest potential anti-inflammatory and antioxidant properties. Most of its role in the cannabis matrix is as a quiet byproduct of plant aging and oxidative transformation.
No established medicinal uses for CBE exist yet. Early laboratory studies have begun to examine its possible effects on inflammation, oxidative stress, and cellular protection, but real-world data and clinical trials are lacking. CBE’s gentle presence may prove valuable in future full-spectrum extracts or aging-related research.
CBE’s natural abundance is extremely low and is primarily a marker for oxidation or product aging. There is little known about its safety, human effects, or long-term impact. Its role in the plant is still mostly symbolic—a witness to the passage of time and transformation.
🔄 Breakdown Witness — Aging Marker — Silent Shield
🌫️ Transformation Signal — Oxidation Emblem — Subtle Protector
⏳ Time’s Byproduct — Gentle Endurance — Quiet Power
Current studies are beginning to explore CBE’s anti-inflammatory and antioxidant effects, as well as its possible use as a marker for cannabis quality, age, and extract preservation. Future research may reveal unique roles in aging, stress response, or cellular protection.
CBE is a silent companion within the evolving world of cannabinoids—a subtle signal of time, change, and resilience. Though its effects remain largely speculative, CBE may one day emerge as a gentle protector or marker of quality in the ever-changing landscape of cannabis science.
We never did this for the money.
We did it because molecules tell stories—stories that bridge healing, curiosity, and responsibility across cultures and generations.
If you feel this work holds value and wish to be part of sustaining independent research, you are warmly invited to stand with us.
🟢 Disclaimer
The information provided on this website is intended solely for general informational and educational purposes related to the scientific analysis and classification of medical cannabis data. It does not constitute medical advice, diagnosis, or treatment recommendations and should not be used as a substitute for professional medical consultation.
All content has been sourced from our proprietary database and is systematically processed, structured, and formatted through our middleware systems. A final validation is performed using a combination of algorithmic quality assurance procedures and editorial review.
While we strive to ensure the highest level of accuracy, completeness, and currency, we make no guarantees regarding the reliability or applicability of the information provided. For any questions related to health, treatment decisions, or the use of medical cannabis, please consult a qualified healthcare professional.
Maria-Theresia-Str. 11
81675 Munich
Germany
